SCHEMBL29854535

CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.60

▸	NPY4R	P50391	8/20	0.60

▸	NPY5R	Q15761	8/20	0.60

▸	NPY1R	P25929	6/20	0.60

▸	OPRM1	P35372	3/20	0.56

▸	OPRD1	P41143	3/20	0.56

▸	OPRK1	P41145	3/20	0.56

▸	TFPI	P10646	2/20	0.54

▸	NMUR2	Q9GZQ4	1/20	0.54

▸	CXCL8	P10145	2/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29854880	1.00	NPY2R (0.60)	NPY2RNPY4RNPY5RNPY1ROPRM1
SCHEMBL29526542	0.95	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1ROPRM1
SCHEMBL29527389	0.95	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1ROPRM1
SCHEMBL29527003	0.94	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1ROPRM1
SCHEMBL29854567	0.90	NPY2R (0.68)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29854544	0.89	NPY2R (0.67)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29527250	0.88	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1ROPRM1
SCHEMBL29854740	0.88	NPY2R (0.59)	NPY2RNPY4RNPY5RNPY1RCXCL8
SCHEMBL29854495	0.88	NPY2R (0.72)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30974098	0.86	NPY2R (0.57)	NPY2RNPY4RNPY5RNPY1ROPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220257719-A1	APPETITE SUPPRESSING COMPOUNDS	IP2IPO INNOVATIONS LIMITED (GB)	2022-08-18	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220257719-A1	APPETITE SUPPRESSING COMPOUNDS	GIPR, GPR119, IAPP	NPY2R 8/4885NPY4R 6/4885NPY5R 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.